This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China Development Financial's stake buy in China Life approved by Taiwan's antitrust regulator

( January 20, 2021, 08:36 GMT | Official Statement) -- MLex Summary: A proposed increase from 34.83 percent to 55.95 percent in the stake owned by China Development Financial in China Life Insurance, both based in Taiwan, has been approved by the Taiwan Fair Trade Commission, the regulator said in a statement. The regulator said there were plenty of competitors in the relevant insurance market and the transaction wouldn’t cause significant competition concerns.The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login